The recent sessions of the World Health Assembly (WHA) have concluded with a series of landmark decisions...
Rescuing Innovation: How the Children’s Tumor Foundation is Unlocking Shelved Rare Disease Therapies
Rescuing Innovation: How the Children’s Tumor Foundation is Unlocking Shelved Rare Disease Therapies
In the high-stakes world of pharmaceutical development, the journey from laboratory bench to patient bedside is often...
By Editorial Staff May 26, 2026 In the book of Deuteronomy, the ancient directive is clear: "Choose...
By Editorial Staff In an era defined by medical breakthroughs and a culture that prizes youth and...
WASHINGTON, D.C. — As the first quarter of the year concludes, the metastatic breast cancer (MBC) advocacy...
Introduction: The Pulse of Patient-Centered Innovation In the relentless pursuit of medical breakthroughs, the role of the...
The landscape of metabolic healthcare is undergoing a seismic shift. Eli Lilly and Company, currently the world’s...
The 79th World Health Assembly (WHA) concluded in Geneva this week, marking a pivotal moment in international...
Introduction: The Unforeseen Return The initial diagnosis of cancer is a seismic event for any family, a...
Introduction: A Personal Commitment to the DRC In a poignant and urgent appeal to the people of...
